OakChart

QTREX Quantum Ltd

QTEXTechnology·Computer Hardware·Israel·Micro·NASD·Nov 11 • 3:59 PM ET

0.9825-0.0375 (-3.68%)
2026-11-12 07:23 CET
Market cap
65.90 USD m
Revenue, TTM
1.55 USD m
Net income, TTM
-13.18 USD m
Free cash flow, TTM
-8.75 USD m
EPS diluted, TTM
-0.35
P/E
-
Compare

Price

QTEX against its 20, 50 and 200-day averages
2050200earnings
Patternshover a marker to name it
Sales mean, own scale
Sales 33.0Price33.01.002.003.004.00394.3M788.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26QTEXclose 0.9820-day 1.2650-day 1.12200-day 0.980.9852w high52w low

74.5% under the 52-week high of 3.85 on 1 Jun 2026. 52-week low 0.28 on 21 May 2026. Last 15 sessions, 65.6% high to low

Volume 0.19× normal · the line is the 50-bar volume average

Profile

QTEX
52-week range, 20% of the way up
0.283.85

QTREX Quantum Ltd. is a specialty medical device company, which engages in research, development, manufacturing, and marketing of proprietary life support technology with a vision to supersede traditional mechanical ventilators, or Mechanical Ventilation, which is the standard of care today for the treatment of acute respiratory failure. The company was founded by Dagi Shahar Ben Noon, Joe Hayon, and Udi Nussinovitch in July 2017 and is headquartered in Raanana, Israel.

Employees40
IPOJul 14, 2021
Beta3.96
ATR, 14d0.14
Rel volume0.19
Short float6.23%
Insider own14.40%
Inst own11.37%

Snapshot

6 groups

Valuation

Index-
Market Cap65.90M
Enterprise Value58.02M
Income-13.18M
Sales1.55M
Book/sh0.19
Cash/sh0.16
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees40
IPOJul 14, 2021

Ratios

P/E-
Forward P/E-
PEG-
P/S42.52
P/B5.07
P/C6.18
P/FCF-
EV/EBITDA-
EV/Sales37.44
Quick Ratio1.62
Current Ratio2.00
Debt/Eq0.26
LT Debt/Eq0.12
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.35
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y31.48% 14.99%
Sales past 3/5Y- -
EPS Y/Y TTM24.01%
Sales Y/Y TTM437.72%
EPS Q/Q95.19%
Sales Q/Q-
EarningsSep 24 BMO
EPS/Sales Surpr.- -

Ownership

Insider Own14.40%
Insider Trans0.71%
Inst Own11.37%
Inst Trans-1.72%
ROA-106.42%
ROE-219.29%
ROIC-109.91%
Gross Margin34.17%
Oper. Margin-858.49%
Profit Margin-847.88%
SMA20-21.71%
SMA50-12.45%
SMA2000.40%
Trades-

Technical

Shs Outstand67.08M
Shs Float57.42M
Short Float6.23%
Short Ratio0.38
Short Interest3.58M
52W High3.85 -74.48%
52W Low0.28 247.17%
Volatility9.94% 9.96%
ATR (14)0.14
RSI (14)39.62
Beta3.96
Rel Volume0.19
Avg Volume9.31M
Volume1,767,828

Performance

Perf Week-2.72%
Perf Month-37.82%
Perf Quarter-1.75%
Perf Half Y142.59%
Perf YTD9.17%
Perf Year-4.61%
Perf 3Y-19.46%
Perf 5Y-74.08%
Perf 10Y-
Recom1.00
Target Price5.00
Prev Close1.02
Price0.98
Change %-3.68%

Peers

Mkt cap
TickerCompanyMkt cap
NNDMNano Dimension Ltd ADR271.32M
RGTIRigetti Computing Inc3.71B
QBTSD-Wave Quantum Inc4.04B
QUBTQuantum Computing Inc1.40B
IONQIonQ Inc14.73B
IQMXIQM Quantum Computers Oyj ADR1.42B
PSQLPasqal Holding SA959.57M
VELOVelo3D Inc157.53M
DDD3D Systems Corp301.09M
FORMFormFactor Inc7.51B

Insider trading

latest 14 of 18
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Parnes TalDirectorOct 15 '26Buy1.506,6669,999766,666Oct 15 10:25 AM
Ben-Noon Dagi ShaharChief Executive OfficerOct 13 '26Buy1.4914,09320,99914,093Oct 13 12:40 PM
Ben-Noon Dagi ShaharChief Executive OfficerOct 09 '26Buy1.6718,18130,3623,664,314Oct 09 11:29 AM
Ben-Noon Dagi ShaharChief Executive OfficerSep 28 '26Buy0.71168,894119,5433,646,133Sep 29 01:49 PM
Yechezkely Hayon DaniellaChief Technology OfficerMay 29 '26Sale3.0050,000150,000780,000Jun 02 04:01 PM
Tehila YafitChief Financial OfficerJun 01 '26Sale3.5028,10098,350870,000Jun 02 04:01 PM
Tehila YafitChief Financial OfficerMay 29 '26Sale3.511,9006,669898,100Jun 02 04:01 PM
shabtay abrahamCOO and VP of R&DMay 29 '26Option Exercise3.3795,239320,9551,332,713Jun 02 04:01 PM
Tehila YafitOfficerJun 01 '26Proposed Sale3.0720,00061,400Jun 01 01:35 PM
Yechezkely Hayon DaniellaOfficerMay 29 '26Proposed Sale3.0050,000150,000Jun 01 06:40 AM
shabtay abrahamOfficerMay 29 '26Proposed Sale3.0095,239285,717Jun 01 06:34 AM
Tehila YafitOfficerMay 29 '26Proposed Sale3.0010,00030,000Jun 01 06:23 AM
Tehila YafitChief Financial OfficerMay 27 '26Option Exercise0.1213,6051,633960,000May 29 03:12 PM
Tehila YafitChief Financial OfficerMay 28 '26Sale2.7830,00083,400900,000May 29 03:12 PM

Held by

AUM
TickerCompanyAUM
QQQSInvesco NASDAQ Future Gen 200 ETFAUM: 20.53M

News

latest 14 of 200
  • QTREX Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire) -6.67%
  • Correction: QTREX Quantum Announces Clean Capital Structure (GlobeNewswire) -7.59%
  • QTREX Quantum Announces Clean Capital Structure (GlobeNewswire)
  • QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader (GlobeNewswire) +15.04%
  • QTREX Quantum Reports First Half 2026 Financial Results (GlobeNewswire)
  • One of Israel's 3 Largest Defense Companies Begins Immediate Deployment of QTREX Quantum's AME Technology (GlobeNewswire)
  • Correction: QTREX Establishes Cryogenic Interconnect Capacity, More Than Four Times the Highest Publicly Disclosed Industry Benchmark (GlobeNewswire)
  • QTREX to Unveil Ultra-High-Density Interconnect Architecture Supporting 17,280 Coaxial Lines per Cryogenic Stage at IEEE Quantum Week 2026 (GlobeNewswire)
  • Qtrex Quantum shares plunge 16% after announcing $10 million stock offering (InvestorsHub) -24.04%
  • QTREX Announces Pricing of a $10 Million Registered Direct Offering of Ordinary Shares (GlobeNewswire)
  • QTREX Achieves Direct Graphene-Like Carbon Conversion for Quantum Processor Protection (InvestorsHub) +24.79%
  • QTREX's Patent-Pending Technology Achieves First Direct Conversion of 3D-Printed Insulation into Graphene-Like Carbon to Protect Quantum Processors (GlobeNewswire)
  • QTREX and U.S. Department of Defense Laboratory Target Q4 2026 to Formalize Joint Quantum Development Program (GlobeNewswire)
  • QTREX Proprietary Quantum Interconnect Platform Exceeds Performance Requirements Established by Strategic Partners (GlobeNewswire) +8.42%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026S12026-09-24-0.140--0.2101.55--
2025S22026-03-26-0.210-0.200-0.2070.000.201
2025S12025-10-01-0.240-0.220-0.2390.290.001
2024S22025-03-11-0.150--0.2220.00--
2023Q32023-11-16-0.220-0.300-0.2070.000.001
2023S12023-08-10-0.500-0.640-0.1500.000.001
2023Q12023-05-18-0.290--0.2590.00-1
2022Q42023-04-04-0.270-0.270-0.2810.000.001
2022Q32022-11-23-0.340--0.3450.00--
2026S2--0.120--33.001

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2022FY-0.950-1.010-1.3870.000.00
2024FY-0.456--0.5970.00-
2025FY-0.450-0.440-0.4500.290.49
2026FY-0.100--48.00

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026S2S2026-03-2710033.0033.0033.00
2026S2S2025-11-1210033.0033.0033.00
2026S2S2025-11-1111033.0033.0033.00
2026S2S2025-11-1011033.0033.0033.00
2026S2S2025-11-0911033.0033.0033.00
2026S2S2025-11-0811033.0033.0033.00
2026S2S2025-11-0711033.0033.0033.00
2026S2S2025-11-0611033.0033.0033.00
2026S2S2025-11-0511033.0033.0033.00
2026S2S2025-11-0411033.0033.0033.00
2026S2S2025-11-0311033.0033.0033.00
2026S2S2025-11-0211033.0033.0033.00
2026S2S2025-11-0111033.0033.0033.00
2026S2S2025-10-3111033.0033.0033.00

Estimate history

EPS, annual-0.339-1.005-3.195-1.387-0.933-0.597-0.446
Period2019202020212022202320242025
EPS, quarterly-0.281-0.259-0.236-0.207
PeriodQ4 '22Q1 '23Q2 '23Q3 '23
Sales, annual0000000.289
Period2019202020212022202320242025
Sales, quarterly0000
PeriodQ4 '22Q1 '23Q2 '23Q3 '23
Shares, annual13.5067.1910.09211.33915.65224.25235.949
Period2019202020212022202320242025
Shares, quarterly11.33911.711.99311.7
PeriodQ4 '22Q1 '23Q2 '23Q3 '23

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue1.550.290.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A1.020.560.490.410.290.220.200.08
Gross Profit0.53-0.27-0.49-0.41-0.29-0.22-0.20-0.08
Selling, General and Administrative Excl. Other13.8713.3410.7711.7214.5911.954.881.01
Research and Development8.297.165.957.038.003.783.680.81
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-13.34-13.61-11.26-12.13-14.89-12.17-5.08-1.09
Interest Expense-0.01-0.010.000.020.070.01
Unusual Expense0.00-0.250.04-0.31-0.113.652.133.48
Net Income Before Taxes-13.18-13.22-11.05-11.29-14.98-16.96-7.23-4.58
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-13.18-13.22-11.05-11.29-14.98-16.96-7.23-4.58
Net Income From Continuing Operations-13.18-13.22-11.05-11.29-14.98-16.96-7.23-4.58
Net Income-13.18-13.22-11.05-11.29-14.98-16.96-7.23-4.58
EPS (Recurring)-0.30-0.45-0.60-0.95-1.39-2.71-0.80-0.16
EPS (Basic, Before Extraordinaries)-0.35-0.45-0.60-0.93-1.39-3.20-1.01-0.34
EPS (Diluted)-0.35-0.45-0.60-0.93-1.39-3.20-1.01-0.34
EBITDA-12.93-13.16-10.77-11.72-14.59-11.95-4.88-1.01
Non-Operating Income (Expense)0.630.160.250.55-0.20-1.120.050.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.673.581.771.434.884.262.350.00
Price To Sales Ratio41.3092.25------
Gross Margin34.17-94.12------
Operating Margin-858.49-4,710.73------
Net Margin-847.88-4,574.39------
Shares Outstanding55.4135.9524.2515.6511.3410.097.1913.51
Market Capitalization65.9065.9018.729.7113.7432.4337.26-

Income statement, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12020S22020S1
Total Revenue1.550.000.290.000.00-0.000.00
Cost of Goods Sold Incl. D&A0.810.210.520.270.22-0.120.08
Gross Profit0.74-0.21-0.23-0.27-0.22--0.12-0.08
Selling, General and Administrative Excl. Other7.706.177.005.205.58-2.852.04
Research and Development4.603.703.472.853.10-2.301.38
Other Operating Expense0.000.000.000.000.00-0.000.00
Operating Income-6.96-6.39-7.23-5.46-5.80--2.97-2.12
Interest Expense-0.46--0.52-0.050.01
Unusual Expense0.000.000.000.000.00--0.092.22
Net Income Before Taxes-6.35-6.82-6.40-4.81-6.24--2.88-4.35
Income Taxes0.000.000.000.000.00-0.000.00
Consolidated Net Income-6.35-6.82-6.40-4.81-6.24--2.88-4.35
Net Income From Continuing Operations-6.35-6.82-6.40-4.81-6.24--2.88-4.35
Net Income-6.35-6.82-6.40-4.81-6.24--2.88-4.35
EPS (Recurring)-0.14-0.21-0.24-0.22-0.38--0.41-0.21
EPS (Basic, Before Extraordinaries)-0.14-0.21-0.24-0.22-0.38--0.40-0.32
EPS (Diluted)-0.14-0.21-0.24-0.22-0.38--0.40-0.32
EBITDA-6.76-6.17-6.99-5.20-5.58--2.85-2.04
Non-Operating Income (Expense)0.600.030.030.650.08-0.050.00
Stock Option Compensation Expense0.851.831.750.790.98-1.351.00
Price To Sales Ratio41.30102.4478.77-----
Gross Margin47.94--80.62-----
Operating Margin-447.55--2,501.04-----
Net Margin-408.88--2,213.84-----
Shares Outstanding55.4135.9528.6524.25--7.1913.51
Market Capitalization65.9032.1421.7818.7225.33---

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments3.265.877.4513.9623.750.500.10
Short Term Receivables0.000.000.000.000.210.190.09
Inventories0.730.440.000.000.000.000.00
Other Current Assets0.420.500.340.530.550.000.00
Total Current Assets4.416.817.7914.4924.510.680.18
Net Property, Plant & Equipment0.931.261.521.671.360.300.19
Total Investments and Advances0.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.00
Other Assets0.000.000.000.000.000.000.00
Total Assets5.348.079.3116.1725.870.990.37
Short Term Debt Incl. Current Port. of LT Debt1.371.851.760.293.500.404.81
Accounts Payable0.110.150.200.150.090.000.07
Other Current Liabilities1.351.361.031.220.720.550.10
Total Current Liabilities2.823.372.981.664.310.954.99
Long Term Debt0.190.380.590.871.201.740.03
Provision for Risks Charges0.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.000.00
Total Liabilities3.023.753.572.545.522.695.01
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.00
Common Equity2.324.325.7413.6320.35-1.70-4.64
Total Shareholders Equity2.324.325.7413.6320.35-1.70-4.64
Accumulated Minority Interest0.000.000.000.000.000.000.00
Total Equity2.324.325.7413.6320.35-1.70-4.64
Total Liabilities & Stockholders Equity5.348.079.3116.1725.870.990.37
Book Value Per Share0.060.180.371.202.02-0.24-0.34
Tangible Book Value Per Share0.060.180.371.202.02-0.24-0.34
Full-Time Employees40484237211212
Price to Book Ratio5.072.781.680.92-17.55-20.17-
Return on Assets-197.15-127.19-89.14-71.25-126.26-1,062.16-
Return on Equity-397.89-219.74-121.62-88.13-181.82--
Return on Invested Capital-525.23-235.17-178.41-103.25-78.66-20,077.78-
Quick Ratio1.301.892.618.725.680.720.04
Current Ratio1.562.022.618.725.680.720.04

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-13.18-13.22-11.05-11.29-14.98-16.96-7.23-4.58
Depreciation0.280.150.170.110.050.240.200.08
Other Funds (Non Cash)2.543.431.941.184.770.000.000.00
Funds from Operations-10.36-9.64-8.94-10.00-10.15-16.72-7.03-4.50
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital1.70-0.22-0.430.240.509.024.260.09
Cash from Operating Activities-8.67-9.86-9.37-9.76-9.65-7.70-2.77-4.41
Capital Expenditures-0.09-0.10-0.16-0.21-0.26-0.18-0.02-0.03
Net Assets From Acquisitions-2.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.060.000.000.000.000.000.000.00
Purchase or Sale of Investments-0.000.671.650.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments-0.000.671.650.000.000.000.000.00
Other Uses0.000.000.000.00-7.12-0.07-0.00-0.04
Other Sources0.000.000.004.800.000.000.000.00
Cash from Investing Activities-2.030.571.494.59-7.38-0.25-0.03-0.07
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock19.307.337.903.450.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock19.307.337.903.450.000.000.000.00
Proceedsfrom Stock Options18.316.417.903.450.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.0015.783.364.65
Change in Long Term Debt0.000.000.000.000.008.760.310.00
Issuance of Long Term Debt0.000.000.000.000.008.760.310.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.0014.660.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.00
Cash from Financing Activities19.307.337.903.450.0030.243.184.56
Exchange Rate Effect-0.010.030.06--1.940.950.010.00
Net Change in Cash8.59-1.940.07-1.71-17.0323.250.400.09
Free Cash Flow-8.75-9.96-9.54-9.96-9.91-7.87-2.79-4.44
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S1
Cash & Short Term Investments10.673.262.225.87--
Short Term Receivables0.820.000.000.00--
Inventories2.810.730.710.44--
Other Current Assets0.740.420.320.50--
Total Current Assets15.044.413.256.81--
Net Property, Plant & Equipment5.270.931.201.26--
Total Investments and Advances0.000.000.000.00--
Intangible Assets0.000.000.000.00--
Other Assets0.000.000.000.00--
Total Assets20.315.344.458.07--
Short Term Debt Incl. Current Port. of LT Debt1.541.371.181.85--
Accounts Payable0.470.111.650.15--
Other Current Liabilities5.521.350.001.36--
Total Current Liabilities7.532.822.833.37--
Long Term Debt1.250.190.350.38--
Other Liabilities0.200.000.000.00--
Total Liabilities8.973.023.173.75--
Non-Equity Reserves0.600.000.000.00--
Preferred Stock - Carrying Value0.000.000.000.00--
Common Equity10.742.321.284.32--
Total Shareholders Equity10.742.321.284.32--
Accumulated Minority Interest0.000.000.000.00--
Total Equity10.742.321.284.32--
Total Liabilities & Stockholders Equity20.315.344.458.07--
Book Value Per Share0.190.060.040.18--
Tangible Book Value Per Share0.190.060.040.18--
Price to Book Ratio5.0720.174.772.78--
Return on Assets-106.42-197.15----
Return on Equity-219.29-397.89----
Return on Invested Capital-53.00-271.04-393.48-102.40--
Quick Ratio1.621.300.901.89--
Current Ratio2.001.561.152.02--

Cash flow, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S1
Net Income-6.35-6.82-6.40-4.81-6.24-
Depreciation0.200.080.070.100.07-
Other Funds (Non Cash)0.242.291.140.311.63-
Funds from Operations-5.91-4.45-5.19-4.40-4.54-
Extraordinary Item0.000.000.000.000.00-
Changes in Working Capital2.02-0.320.10-0.12-0.31-
Cash from Operating Activities-3.89-4.77-5.09-4.52-4.86-
Capital Expenditures-0.09-0.00-0.10-0.16-0.00-
Net Assets From Acquisitions-2.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.060.000.000.000.00-
Purchase or Sale of Investments0.00-0.000.673.04-1.39-
Purchase of Investments0.000.000.001.39-1.39-
Sale Or Maturity of Investments0.00-0.000.671.650.00-
Other Uses0.000.000.000.000.00-
Other Sources0.000.000.00-0.000.00-
Cash from Investing Activities-2.03-0.000.572.88-1.39-
Cash Dividends Paid0.000.000.000.000.00-
Preferred Dividends (Cash Flow)0.000.000.000.000.00-
Change in Capital Stock13.495.811.523.154.76-
Repurchase of Common Pref Stock0.000.000.000.000.00-
Sale of Common Pref Stock13.495.811.523.154.76-
Proceedsfrom Stock Options13.424.891.513.154.75-
Issuance or Reduction of Debt, Net0.000.000.000.000.00-
Change in Long Term Debt0.000.000.000.000.00-
Issuance of Long Term Debt0.000.000.000.000.00-
Reduction of Long Term Debt0.000.000.000.000.00-
Net Financing Active Other Cash Flow0.000.000.000.000.00-
Other Financing Activities Uses0.000.000.000.000.00-
Cash from Financing Activities13.495.811.523.154.76-
Exchange Rate Effect-0.020.000.02---
Net Change in Cash7.551.04-2.981.56-1.49-
Free Cash Flow-3.98-4.78-5.19-4.68-4.86-

Revenue breakdown

Surgical & Medical Instruments & Apparatus2025: 289.00K
Israel2025: 289.00K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.23%3.6M57.4M9.19M
2026-10-157.50%4.3M57.4M8.83M
2026-09-305.64%3.3M58.6M2.93M
2026-09-156.47%3.8M58.6M4.50M
2026-08-316.55%3.8M58.6M9.47M
2026-08-149.65%3.7M38.0M29.89M
2026-07-318.04%3.1M38.0M29.70M
2026-07-156.53%2.5M38.0M29.69M
2026-06-306.50%2.7M41.6M28.47M
2026-06-157.71%3.3M42.6M26.18M
2026-05-2919.29%8.2M42.6M21.28M
2026-04-302.16%0.9M41.9M684.93K
2026-04-152.10%0.9M41.9M648.30K
2026-03-310.85%0.4M42.4M613.69K
2026-03-131.03%0.4M42.1M591.65K
2026-02-271.05%0.4M42.1M586.55K
2026-02-131.52%0.6M42.1M577.30K
2026-01-300.74%0.3M34.8M172.43K
2026-01-150.82%0.3M34.8M189.30K
2025-12-310.76%0.3M34.5M197.24K

Option chain

expiry 2026-11-12
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-196-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-19SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-13SEC
2026-10-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-09SEC
2026-10-094Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-10-016-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-01SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-294/A2026-08-28SEC
2026-09-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-30SEC
2026-09-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-02SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-08-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-28SEC
2026-08-27SCHEDULE 13GSEC
2026-08-21424B5SEC
2026-08-206-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-20SEC
2026-08-196-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-19SEC
2026-08-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-03SEC
2026-07-31EFFECTEffectiveness filing by commission orderSEC
2026-07-28CORRESPSEC
2026-07-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-27SEC
2026-07-27UPLOADUpload SubmissionSEC
2026-07-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-24SEC
2026-07-223Initial statement of beneficial ownership of securities2026-07-14SEC
2026-07-21F-1Registration statement for certain foreign private issuersSEC
2026-07-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-21SEC
2026-07-21S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-07-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-17SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-1061.36K300
2026-09119.54K100
2026-080000
2026-070000
2026-060098.35K1
2026-0500300.63K4
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
CITADEL ADVISORS LLC3.25%
Caitong International Asset Management Co., Ltd0.57%
FOUNDATIONS INVESTMENT ADVISORS, LLC0.45%
JANE STREET GROUP, LLC0.33%
SLT Holdings LLC0.27%
Virtu Financial LLC0.25%
UBS Group AG0.22%
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.12%
Kestra Advisory Services, LLC0.12%
XTX Topco Ltd0.12%

Funds

Fund% owned
VANGUARD TOTAL INTERNATIONAL BOND II INDEX FUND13.54%
VANGUARD TOTAL INTERNATIONAL BOND INDEX FUND11.70%
Invesco NASDAQ Future Gen 200 ETF0.05%
Fidelity Nasdaq Composite Index Fund0.01%

OakChart. QTEX. Cached 15 minutes.

Some panels did not load: ratings.